Literature DB >> 23527542

Getting away with murder: how does the BCL-2 family of proteins kill with immunity?

Thibaud T Renault1, Jerry E Chipuk.   

Abstract

The adult human body produces approximately one million white blood cells every second. However, only a small fraction of the cells will survive because the majority is eliminated through a genetically controlled form of cell death known as apoptosis. This review places into perspective recent studies pertaining to the BCL-2 family of proteins as critical regulators of the development and function of the immune system, with particular attention on B cell and T cell biology. Here we discuss how elegant murine model systems have revealed the major contributions of the BCL-2 family in establishing an effective immune system. Moreover, we highlight some key regulatory pathways that influence the expression, function, and stability of individual BCL-2 family members, and discuss their role in immunity. From lethal mechanisms to more gentle ones, the final portion of the review discusses the nonapoptotic functions of the BCL-2 family and how they pertain to the control of immunity.
© 2013 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23527542      PMCID: PMC3663908          DOI: 10.1111/nyas.12045

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  174 in total

1.  Mono- and multisite phosphorylation enhances Bcl2's antiapoptotic function and inhibition of cell cycle entry functions.

Authors:  Xingming Deng; Fengqin Gao; Tammy Flagg; W Stratford May
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-05       Impact factor: 11.205

2.  Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival.

Authors:  Mohamed Elgendy; Clare Sheridan; Gabriela Brumatti; Seamus J Martin
Journal:  Mol Cell       Date:  2011-02-25       Impact factor: 17.970

3.  The mitochondrial fission factor dynamin-related protein 1 modulates T-cell receptor signalling at the immune synapse.

Authors:  Francesc Baixauli; Noa B Martín-Cófreces; Giulia Morlino; Yolanda R Carrasco; Carmen Calabia-Linares; Esteban Veiga; Juan M Serrador; Francisco Sánchez-Madrid
Journal:  EMBO J       Date:  2011-02-15       Impact factor: 11.598

4.  Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1.

Authors:  Joseph T Opferman; Anthony Letai; Caroline Beard; Mia D Sorcinelli; Christy C Ong; Stanley J Korsmeyer
Journal:  Nature       Date:  2003-12-11       Impact factor: 49.962

5.  Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma.

Authors:  Pilar Caro; Amar U Kishan; Erik Norberg; Illana A Stanley; Bjoern Chapuy; Scott B Ficarro; Klaudia Polak; Daniel Tondera; John Gounarides; Hong Yin; Feng Zhou; Michael R Green; Linfeng Chen; Stefano Monti; Jarrod A Marto; Margaret A Shipp; Nika N Danial
Journal:  Cancer Cell       Date:  2012-10-16       Impact factor: 31.743

6.  Elevated Mcl-1 inhibits thymocyte apoptosis and alters thymic selection.

Authors:  K J Campbell; D H D Gray; N Anstee; A Strasser; S Cory
Journal:  Cell Death Differ       Date:  2012-06-29       Impact factor: 15.828

7.  The BH3-only proteins Bim and Puma cooperate to impose deletional tolerance of organ-specific antigens.

Authors:  Daniel H D Gray; Fiona Kupresanin; Stuart P Berzins; Marco J Herold; Lorraine A O'Reilly; Philippe Bouillet; Andreas Strasser
Journal:  Immunity       Date:  2012-09-06       Impact factor: 31.745

8.  Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins.

Authors:  Tina Cirman; Kristina Oresić; Gabriela Droga Mazovec; Vito Turk; John C Reed; Richard M Myers; Guy S Salvesen; Boris Turk
Journal:  J Biol Chem       Date:  2003-10-27       Impact factor: 5.157

9.  The Zinc-finger protein ASCIZ regulates B cell development via DYNLL1 and Bim.

Authors:  Sabine Jurado; Kimberly Gleeson; Kristy O'Donnell; David J Izon; Carl R Walkley; Andreas Strasser; David M Tarlinton; Jörg Heierhorst
Journal:  J Exp Med       Date:  2012-08-13       Impact factor: 14.307

10.  Minor cell-death defects but reduced tumor latency in mice lacking the BH3-only proteins Bad and Bmf.

Authors:  F Baumgartner; C Woess; V Pedit; A Tzankov; V Labi; A Villunger
Journal:  Oncogene       Date:  2012-03-19       Impact factor: 9.867

View more
  19 in total

Review 1.  Apoptotic and autophagic pathways with relevant small-molecule compounds, in cancer stem cells.

Authors:  Lan Zhang; Xupeng Tong; Jingjing Li; Yue Huang; Xinyue Hu; Yi Chen; Jian Huang; Jinhui Wang; Bo Liu
Journal:  Cell Prolif       Date:  2015-05-25       Impact factor: 6.831

2.  A systems genetics approach delineates the role of Bcl2 in leukemia pathogenesis.

Authors:  Xinfeng Wang; Akhilesh Kumar Bajpai; Qingqing Gu; Arthur Centeno; Athena Starlard-Davenport; Pjotr Prins; Fuyi Xu; Lu Lu
Journal:  Leuk Res       Date:  2022-02-09       Impact factor: 3.715

Review 3.  Memory responses of natural killer cells.

Authors:  Clair D Geary; Joseph C Sun
Journal:  Semin Immunol       Date:  2017-08-30       Impact factor: 11.130

4.  Gimap and T cells: a matter of life or death.

Authors:  Thomas Ciucci; Rémy Bosselut
Journal:  Eur J Immunol       Date:  2014-02       Impact factor: 5.532

5.  A New G-Quadruplex with Hairpin Loop Immediately Upstream of the Human BCL2 P1 Promoter Modulates Transcription.

Authors:  Buket Onel; Megan Carver; Guanhui Wu; Daria Timonina; Salil Kalarn; Marti Larriva; Danzhou Yang
Journal:  J Am Chem Soc       Date:  2016-02-22       Impact factor: 15.419

Review 6.  MicroRNAs affect BCL-2 family proteins in the setting of cerebral ischemia.

Authors:  Yi-Bing Ouyang; Rona G Giffard
Journal:  Neurochem Int       Date:  2013-12-25       Impact factor: 3.921

7.  Anticancer compound ABT-263 accelerates apoptosis in virus-infected cells and imbalances cytokine production and lowers survival rates of infected mice.

Authors:  L Kakkola; O V Denisova; J Tynell; J Viiliäinen; T Ysenbaert; R C Matos; A Nagaraj; T Ohman; S Kuivanen; H Paavilainen; L Feng; B Yadav; I Julkunen; O Vapalahti; V Hukkanen; J Stenman; T Aittokallio; E W Verschuren; P M Ojala; T Nyman; X Saelens; K Dzeyk; D E Kainov
Journal:  Cell Death Dis       Date:  2013-07-25       Impact factor: 8.469

Review 8.  Targeting the mitochondrial apoptotic pathway: a preferred approach in hematologic malignancies?

Authors:  K Brinkmann; H Kashkar
Journal:  Cell Death Dis       Date:  2014-03-06       Impact factor: 8.469

Review 9.  Putting the pieces together: How is the mitochondrial pathway of apoptosis regulated in cancer and chemotherapy?

Authors:  Rana Elkholi; Thibaud T Renault; Madhavika N Serasinghe; Jerry E Chipuk
Journal:  Cancer Metab       Date:  2014-10-06

10.  Post-transcriptional regulation of BCL2 mRNA by the RNA-binding protein ZFP36L1 in malignant B cells.

Authors:  Anna Zekavati; Asghar Nasir; Amor Alcaraz; Maceler Aldrovandi; Phil Marsh; John D Norton; John J Murphy
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.